A total of 104 medicines were authorised for marketing in 2025 in the European Union, 38 of which contain a new active substance, the European regulator announced on Thursday. “This is the second-highest number in the past 15 years,” only exceeded in that period by the market-introduction recommendations approved in 2024, the director ... said.